Month: March 2026

TAMPA, Fla. and LONDON, March 17, 2026 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel RNA splice modulating payloads, today announced that the Company will change the ratio of its American Depositary Shares (ADSs) to ordinary shares from one ADS representing two thousand (2,000) ordinary shares to a new ratio of one ADS representing eighty thousand (80,000) ordinary shares. The ratio change is expected to be effective on March 31, 2026. The ratio change is intended to enable Akari to maintain compliance with the Nasdaq minimum bid price requirement for continued listing. On the effective date, each ADS holder will be required to exchange every forty ADSs for one new ADS. Deutsche Bank, the depositary bank, will arrange for the exchange...

CALGARY, Alberta, March 17, 2026 (GLOBE NEWSWIRE) — Further to TransAlta Corporation’s (TransAlta or the Company) (TSX: TA) (NYSE: TAC) press release dated March 2, 2026, the Company announced today that none of its 9,629,913 currently outstanding Cumulative Redeemable Rate Reset First Preferred Shares, Series A (Series A Shares) will be converted on March 31, 2026, on a one-for-one basis, into Cumulative Redeemable Floating Rate First Preferred Shares, Series B (Series B Shares), and (ii) 1,148,549 of its 2,370,087 currently outstanding Series B Shares will be converted on March 31, 2026, on a one-for-one basis, into Series A Shares. As a result, on March 31, 2026, the Company will have 10,778,462 Series A Shares issued and outstanding and 1,221,538 Series B Shares issued and outstanding. The Series A Shares and Series B...

CALGARY, Alberta, March 17, 2026 (GLOBE NEWSWIRE) — TransAlta Corporation (TransAlta or the Company) (TSX: TA) (NYSE: TAC) confirms that its subsidiary, TransAlta Centralia Generation LLC, has received an order (The Order) from the United States Department of Energy. The Order mandates that Centralia Unit 2 in Washington State remain available for operation, for a period of 90 days, until June 14, 2026. TransAlta is currently evaluating the Order and will work with the state and federal governments in relation thereto.  About TransAlta Corporation: TransAlta is one of Canada’s largest publicly traded power generators, delivering reliable electricity across Canada, the United States and Western Australia. For more than 100 years, our people have safely operated and evolved essential energy infrastructure that powers customers and...

NNIT A/S today announces that Claus Rydkjær has been appointed Chief Executive Officer, joining the company as of April 7, 2026. Claus Rydkjær will succeed Pär Fors, who in January announced his decision to step down after almost five years in the role. Chairman of the Board Carsten Dilling comments:“NNIT is entering an important next phase of executing our strategy with a strong focus on growing our footprint in life sciences internationally and the public sector in Denmark. Claus brings more than 25 years of leadership experience from large-scale consulting and technology-enabled services businesses. His deep understanding of strategy and growth execution as well as value-based consulting makes him the right person to take NNIT to the next level.” Claus Rydkjær joins NNIT with extensive executive experience from leading international...

SANTA MONICA, Calif., March 17, 2026 (GLOBE NEWSWIRE) — Super League (Nasdaq: SLE) (the “Company”), an audience intelligence and media activation company connecting brands with people who play video games, one of the largest and most value audiences shaping modern culture, announced today that the Company will post its fourth quarter and full year 2025 financial results before market open on Friday, March 27, 2026. A webinar will be held the same day at 8:30 am Eastern Time to discuss the results and can be accessed using the below dial-in numbers or registration link. Super League Fourth Quarter and Full Year 2025 Earnings WebinarDate: Friday, March 27, 2026Time: 8:30 am Eastern TimeDial-in: 1-877-407-0779International Dial-in: 1-201-389-0914Webinar: Register Here   A replay will be available within 24 hours...

Dallas, Texas, March 17, 2026 (GLOBE NEWSWIRE) — Mangoceuticals, Inc. (NASDAQ: MGRX) (“Mangoceuticals,” the “Company,” or “MangoRx”), a company focused on developing, marketing, and selling health and wellness products through a secure telemedicine platform under the brands MangoRx and PeachesRx, today announced that it has filed a civil lawsuit against Clarity Ventures, Inc., its former technology consulting and software development firm (“Clarity”). The lawsuit, filed in Texas state court, seeks damages exceeding $73 million, exclusive of interest, costs, and attorneys’ fees. The Company alleges that Clarity failed to deliver a fully functional, HIPAA-compliant enterprise resource planning (“ERP”) and eCommerce platform that Clarity had been engaged to design and implement in support of the Company’s operations. Clarity has denied...

Vancouver, British Columbia, March 17, 2026 (GLOBE NEWSWIRE) — Terra Balcanica Resources Corp. (“Terra” or the “Company”) (CSE:TERA; FRA:UB1; OTC:TEBAF) is pleased to announce additional high-grade assay results from the Phase III drill campaign at the Cumavici Ridge polymetallic, epithermal vein target within its Viogor-Zanik project in eastern Bosnia and Herzegovina. HighlightsDrillhole CMV25005 intersected 607 g/t Ag Eq. over 3.0 m including:842 g/t Ag Eq which includes 3.05% Sb over 1.7m;Drillhole CMV25006 intersected 670 g/t Ag Eq. over 3.9 m including:2115 g/t Ag Eq which includes 9.58% Sb over 1.0 m;Step out drillholes located 65 m northwest of CMV25004 which reported 636 g/t Ag Eq. over 4.3 m and 38 m SW of CMVD005 which intercepted 326 g/t Ag Eq. over 10 m;Results confirm the high-grade nature and...